Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010

Dispatch

Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009

Antonio Piralla, Francesca Rovida, Fausto Baldanti, and Giuseppe GernaComments to Author 
Author affiliations: Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico, San Matteo, Pavia, Italy

Main Article

Table

Characteristics of 5 patients with HEV genotype EV-104 infection, Pavia, Italy, 2009*

Patient no. Sample no. Age, y/sex Hospital department, date of admission Respiratory secretion Ct value
Clinical symptoms Underlying disease Virus identified/ coinfecting virus (Ct)
HEV HRV
Pav-1 NPA/9210 60/M Hematology outpatient, Apr 29.67 Undetected Fever, cough, rhinorrhea HSCT (AML) EV-104
Pav-2 NPA/9570 62/M Infectious Diseases outpatient, Apr 23.06 23.05 Chronic rhinopharyngitis None EV-104
Pav-3 NPA/11228 7/F Pediatric Oncohematology, May 33.64 Undetected Fever, rhinorrhea, conjunctivitis AML (chemotherapy) EV-104
Pav-4 NPA/11230 37/F Infectious Diseases outpatient, May 32.60 Undetected Chronic rhinopharyngitis None EV-104
Pav-5 NPA/13174 2/M Pediatric Oncohematology, Jun 23.78 31.61 Cough, rhinorrhea, diarrhea, wheezing HSCT (AML) EV-104/RSV (18.53)

*HEV, human enterovirus; Ct, cycle threshold; HRV, human rhinovirus; NPA, nasopharyngeal aspirate; HSCT, hematopoietic stem cell transplant; AML, acute myelocytic leukemia; RSV, respiratory syncytial virus.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO